(Stroke. 1996;27:44-48.)
© 1996 American Heart Association, Inc.
Articles |
Ischemic Stroke in the Elderly
Role of the Common Factor V Mutation Causing Resistance to ActivatedProtein C
From the Departments of Pathology (R.D.P., X.-Y.L.) and Neurology (N.B., B.M.C.), Oregon Health Sciences University, and the Veteran's Affairs Medical Center (N.B., B.M.C.), Portland, Ore.
Correspondence to Oregon Health Sciences University, Department of Pathology, Mail Code L113, 3181 SW Sam Jackson Park Rd, Portland, OR 97201-3098. E-mail pressr@ohsu.edu.
Background and Purpose A common missense mutation in coagulation factor V (Arg 506 Gln) creates phenotypic resistance to the anticoagulant effects of activated protein C and predisposes carriers to venous thrombosis. To assess a correlation between this common hypercoagulable state and ischemic cerebrovascular disease, we have compared the prevalence of this mutation in a group of stroke patients with that in several control patient groups.
Methods The presence of the factor V Arg 506 Gln mutation was determined by a direct polymerase chain reaction–based assay on peripheral blood leukocytes from 161 elderly patients with acute ischemic stroke, 116 elderly patients with stroke risk factors but without acute stroke, 54 healthy elderly control subjects, and 287 younger control individuals (197 blood donors and 90 neonates).
Results The prevalence of the heterozygous Arg 506 Gln
factor V mutation was not significantly different in the elderly stroke
patients (2.5%) compared with either of the age-matched control
groups (2% to 4%). The prevalence of this mutation was significantly
higher in each of two younger control groups (
8%) than in the
elderly stroke patients (2.5%).
Conclusions The common factor V Arg 506 Gln mutation predisposing to venous thrombosis is not a significant genetic risk factor for ischemic stroke in the elderly.
Key Words: blood coagulation • cerebrovascular disorders • mutation • risk factors • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  G. Celiker, U. Can, H. Verdi, A. C. Yazici, N. Ozbek, and F. B. Atac Prevalence of Thrombophilic Mutations and ACE I/D Polymorphism in Turkish Ischemic Stroke Patients Clinical and Applied Thrombosis/Hemostasis, August 1, 2009; 15(4): 415 - 420. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Gokben, A. Tosun, N. Bayram, G. Serdaroglu, M. Polat, K. Kavakli, and H. Tekgul Arterial Ischemic Stroke in Childhood: Risk Factors and Outcome in Old Versus New Era J Child Neurol, October 1, 2007; 22(10): 1204 - 1208. [Abstract] [PDF]
|
|
|
|
|
|
N. Buyru, J. Altinisik, G. Somay, and T. Ulutin Factor V Leiden Mutation in Cerebrovascular Disease Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 339 - 342. [Abstract] [PDF]
|
|
|
|
 |
|
 J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Juul, A. Tybjarg-Hansen, R. Steffensen, S. Kofoed, G. Jensen, and B. G. Nordestgaard Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses Blood, June 17, 2002; 100(1): 3 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Strater, K. Kurnik, C. Heller, R. Schobess, P. Luigs, and U. Nowak-Gottl Aspirin Versus Low-Dose Low-Molecular-Weight Heparin: Antithrombotic Therapy in Pediatric Ischemic Stroke Patients: A Prospective Follow-Up Study Stroke, November 1, 2001; 32(11): 2554 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lopaciuk, K. Bykowska, H. Kwiecinski, A. Mickielewicz, A. Czlcankawska, T. Mendel, A. Kuczynska-Zardzewialy, D. Szelagowska, J. Windyga, W. Schroder, et al. Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 346 - 350. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Hankey, J. W. Eikelboom, F. M. van Bockxmeer, E. Lofthouse, N. Staples, and R. I. Baker Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes Stroke, August 1, 2001; 32(8): 1793 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mira, J. Todoli, R. Alonso, M. L. Mico, A. Vaya, F. Ferrando, A. Estelles, P. Villa, and J. Aznar Factor V Leiden and Prothrombin G20210A in Relation to Arterial and/or Vein Rethrombosis: Two Cases Clinical and Applied Thrombosis/Hemostasis, July 1, 2001; 7(3): 234 - 237. [Abstract] [PDF]
|
|
|
|
|
|
C. D. Bushnell and L. B. Goldstein Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke Stroke, December 1, 2000; 31(12): 3067 - 3078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hisar, M. Ileri, E. Yetkin, R. Atak, K. Senen, F. Kosar, S. Dundar, and D. Demirkan Role of Activated Protein C Resistance in Left Atrial Thrombogenesis in Patients with Mitral Stenosis Angiology, October 1, 2000; 51(10): 855 - 860. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Hassan and H. S. Markus Genetics and ischaemic stroke Brain, September 1, 2000; 123(9): 1784 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Nowak-Gottl, R. Strater, A. Heinecke, R. Junker, H.-G. Koch, G. Schuierer, and A. von Eckardstein Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood Blood, December 1, 1999; 94(11): 3678 - 3682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kenet, J. Freedman, B. Shenkman, E. Regina, F. Brok-Simoni, F. Holzman, F. Vavva, N. Brand, A. Michelson, M. Trolliet, et al. Plasma Glutathione Peroxidase Deficiency and Platelet Insensitivity to Nitric Oxide in Children With Familial Stroke Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 2017 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Margaglione, G. D'Andrea, N. Giuliani, V. Brancaccio, D. De Lucia, E. Grandone, V. De Stefano, P. A. Tonali, and G. Di Minno Inherited Prothrombotic Conditions and Premature Ischemic Stroke : Sex Difference in the Association With Factor V Leiden Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1751 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kiechl, A. Muigg, P. Santer, M. Mitterer, G. Egger, M. Oberhollenzer, F. Oberhollenzer, A. Mayr, A. Gasperi, W. Poewe, et al. Poor Response to Activated Protein C as a Prominent Risk Predictor of Advanced Atherosclerosis and Arterial Disease Circulation, February 9, 1999; 99(5): 614 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Ganesan, M A McShane, R Liesner, J Cookson, I Hann, and F J Kirkham Inherited prothrombotic states and ischaemic stroke in childhood J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 508 - 511. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Meschia, J. Biller, T. Witt, A. Greist, and S. N. Rhinehart Is Hormone Replacement a Risk Factor for Ischemic Stroke in Women With Factor V Leiden Mutation? Arch Neurol, August 1, 1998; 55(8): 1137 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Serena, T. Segura, M. J. Perez-Ayuso, J. Bassaganyas, A. Molins, and A. Davalos The Need to Quantify Right-to-Left Shunt in Acute Ischemic Stroke : A Case-Control Study Stroke, July 1, 1998; 29(7): 1322 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Longstreth Jr, F. R. Rosendaal, D. S. Siscovick, H. L. Vos, S. M. Schwartz, B. M. Psaty, T. E. Raghunathan, T. D. Koepsell, and P. H. Reitsma Risk of Stroke in Young Women and Two Prothrombotic Mutations: Factor V Leiden and Prothrombin Gene Variant (G20210A) Stroke, March 1, 1998; 29(3): 577 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S Markus and H. Hambley Neurology and the blood: haematological abnormalities in ischaemic stroke J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 150 - 159. [Full Text] [PDF]
|
|
|
|
|
|
G. Orlandi, A. Pellegrinetti, C. Fioretti, A. Martini, and L. Murri Factor V Leiden Mutation in a Case with Ischemic Stroke: which Relationship?: A Case Report Angiology, January 1, 1998; 49(1): 79 - 82. [Abstract] [PDF]
|
|
|
|
|
|
B. Zoller, A. Hillarp, and B. Dahlback State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications Clinical and Applied Thrombosis/Hemostasis, January 1, 1997; 3(1): 25 - 32. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Brey and B. M. Coull Cerebral Venous Thrombosis: Role of Activated Protein C Resistance and Factor V Gene Mutation Stroke, October 1, 1996; 27(10): 1719 - 1720. [Full Text]
|
|
|
|
|
|
M. Fisher, J. A. Fernandez, S. F. Ameriso, D. Xie, A. Gruber, A. Paganini-Hill, and J. H. Griffin Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine506->Glutamine Mutation Stroke, July 1, 1996; 27(7): 1163 - 1166. [Abstract] [Full Text]
|
|